• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current prospects and future challenges for nasal vaccine delivery.鼻腔疫苗递送的当前前景与未来挑战
Hum Vaccin Immunother. 2017 Jan 2;13(1):34-45. doi: 10.1080/21645515.2016.1239668. Epub 2016 Dec 9.
2
Emerging Trends and Future Challenges of Nanovaccine Delivery Nasal Route.纳米疫苗递送的新兴趋势与未来挑战——鼻腔途径
Curr Drug Targets. 2023;24(3):261-273. doi: 10.2174/1389450124666221205162256.
3
Intranasal delivery of nanoparticle-based vaccines.基于纳米颗粒的疫苗的鼻内递送。
Ther Deliv. 2017 Jan;8(3):151-167. doi: 10.4155/tde-2016-0068.
4
Nasal vaccines.鼻用疫苗
Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):21-42. doi: 10.1016/s0169-409x(01)00162-4.
5
Biomineralized vaccine nanohybrid for needle-free intranasal immunization.用于无针鼻内免疫的生物矿化疫苗纳米杂化材料
Biomaterials. 2016 Nov;106:286-94. doi: 10.1016/j.biomaterials.2016.08.035. Epub 2016 Aug 22.
6
Nasal vaccine innovation.鼻腔疫苗创新。
J Drug Target. 2010 Dec;18(10):771-86. doi: 10.3109/1061186X.2010.523790.
7
Nasal route for vaccine and drug delivery: Features and current opportunities.鼻腔给药用于疫苗和药物传输:特点和当前机遇。
Int J Pharm. 2019 Dec 15;572:118813. doi: 10.1016/j.ijpharm.2019.118813. Epub 2019 Oct 31.
8
Delivery systems: a vaccine strategy for overcoming mucosal tolerance?递送系统:一种克服黏膜耐受性的疫苗策略?
Expert Rev Vaccines. 2009 Jan;8(1):103-12. doi: 10.1586/14760584.8.1.103.
9
Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.壳聚糖纳米颗粒作为疫苗黏膜免疫递送载体的研究进展及潜在应用
Curr Drug Deliv. 2017;14(1):27-35. doi: 10.2174/1567201813666160804121123.
10
Development of a nanogel-based nasal vaccine as a novel antigen delivery system.基于纳米凝胶的鼻腔疫苗的开发作为一种新型抗原传递系统。
Expert Rev Vaccines. 2017 Dec;16(12):1231-1240. doi: 10.1080/14760584.2017.1395702. Epub 2017 Oct 27.

引用本文的文献

1
Toll-like receptors (TLRs) in the trained immunity era.训练免疫时代的Toll样受体(TLRs)
Elife. 2025 Sep 2;14:e106443. doi: 10.7554/eLife.106443.
2
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines.鼻内递送mRNA脂质纳米颗粒疫苗后货物递送与免疫原性的去卷积分析
Mol Ther Nucleic Acids. 2025 Apr 24;36(2):102547. doi: 10.1016/j.omtn.2025.102547. eCollection 2025 Jun 10.
3
Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases.纳米技术推动的针对传染病的鼻内疫苗递送系统的进展。
Front Immunol. 2025 May 9;16:1573037. doi: 10.3389/fimmu.2025.1573037. eCollection 2025.
4
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1).靶向呼吸道病毒:鼻内mRNA疫苗在产生针对甲型H1N1流感的保护性黏膜和全身免疫方面的效果
Influenza Other Respir Viruses. 2025 Mar;19(3):e70093. doi: 10.1111/irv.70093.
5
Product and trial design considerations on the path towards a vaccine to combat opioid overdose.对抗阿片类药物过量的疫苗研发过程中的产品与试验设计考量
NPJ Vaccines. 2025 Feb 19;10(1):35. doi: 10.1038/s41541-025-01083-3.
6
Mucosal vaccination with outer membrane vesicles derived from reduces nasal bacterial colonization after experimental infection.用源自[具体来源未给出]的外膜囊泡进行黏膜疫苗接种可减少实验性感染后的鼻腔细菌定植。
Front Immunol. 2024 Nov 28;15:1506638. doi: 10.3389/fimmu.2024.1506638. eCollection 2024.
7
Acceptance of New Respiratory Syncytial Virus Vaccine among Pregnant Women in Nepal for Future Routine Immunization: A Descriptive Crosssectional Study.尼泊尔孕妇对新型呼吸道合胞病毒疫苗用于未来常规免疫的接受情况:一项描述性横断面研究
JNMA J Nepal Med Assoc. 2024 May 31;62(274):372-377. doi: 10.31729/jnma.8622.
8
Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery.细菌膜囊泡的喷雾干燥用于疫苗传递。
Methods Mol Biol. 2024;2843:163-175. doi: 10.1007/978-1-0716-4055-5_11.
9
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗:黏膜疫苗接种与局部免疫的优势
Vaccines (Basel). 2024 Jul 18;12(7):795. doi: 10.3390/vaccines12070795.
10
From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 2019.从肌肉注射到鼻腔给药:释放鼻喷式疫苗对抗2019冠状病毒病的潜力。
Clin Transl Immunology. 2024 May 20;13(5):e1514. doi: 10.1002/cti2.1514. eCollection 2024.

本文引用的文献

1
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.人类免疫缺陷病毒疫苗联合抗逆转录病毒预防对猿猴免疫缺陷病毒攻击的非人灵长类动物具有更高疗效
J Virol. 2016 May 12;90(11):5315-5328. doi: 10.1128/JVI.00230-16. Print 2016 Jun 1.
2
Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.经鼻递送的吸附于聚ε-己内酯基纳米颗粒上的低剂量乙肝表面抗原引发的免疫反应。
Int J Pharm. 2016 May 17;504(1-2):59-69. doi: 10.1016/j.ijpharm.2016.03.013. Epub 2016 Mar 11.
3
Protective role of Th17 cells in pulmonary infection.辅助性T细胞17在肺部感染中的保护作用。
Vaccine. 2016 Mar 18;34(13):1504-1514. doi: 10.1016/j.vaccine.2016.02.021. Epub 2016 Feb 13.
4
Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.新型壳聚糖纳米颗粒/DNA复合物经鼻给药诱导小鼠对乙型肝炎表面抗原产生抗体反应。
Mol Pharm. 2016 Feb 1;13(2):472-82. doi: 10.1021/acs.molpharmaceut.5b00707. Epub 2016 Jan 12.
5
Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery.用于可控基因递送的纳米颗粒包纳米颗粒系统——聚合物-阳离子肽复合纳米颗粒的研发。
Int J Nanomedicine. 2015 Nov 24;10:7183-96. doi: 10.2147/IJN.S95245. eCollection 2015.
6
NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.基于霍乱毒素的疫苗局部免疫后,NKp46+天然淋巴细胞会抑制阴道CD8 T细胞反应。
PLoS One. 2015 Dec 2;10(12):e0143224. doi: 10.1371/journal.pone.0143224. eCollection 2015.
7
Maintenance of Immune Homeostasis through ILC/T Cell Interactions.通过固有淋巴细胞/ T细胞相互作用维持免疫稳态。
Front Immunol. 2015 Aug 13;6:416. doi: 10.3389/fimmu.2015.00416. eCollection 2015.
8
A novel intranasal breath-powered delivery system for sumatriptan: a review of technology and clinical application of the investigational product AVP-825 in the treatment of migraine.一种用于舒马曲坦的新型鼻内呼吸驱动给药系统:研究产品AVP-825治疗偏头痛的技术与临床应用综述
Expert Opin Drug Deliv. 2015;12(9):1565-77. doi: 10.1517/17425247.2015.1060959. Epub 2015 Jun 29.
9
Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysis.泰国儿童季节性流感疫苗接种:一项成本效益分析。
PLoS Med. 2015 May 26;12(5):e1001829; discussion e1001829. doi: 10.1371/journal.pmed.1001829. eCollection 2015 May.
10
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.含22毫克舒马曲坦粉末的AVP - 825呼吸驱动鼻内给药系统与100毫克口服舒马曲坦用于偏头痛急性治疗的比较(COMPASS研究):一项针对多次发作的比较随机临床试验
Headache. 2015 May;55(5):621-35. doi: 10.1111/head.12583. Epub 2015 May 4.

鼻腔疫苗递送的当前前景与未来挑战

Current prospects and future challenges for nasal vaccine delivery.

作者信息

Yusuf Helmy, Kett Vicky

机构信息

a School of Pharmacy, Queen's University of Belfast , Belfast , Antrim , UK.

b School of Pharmacy, Queen's University of Belfast , Belfast , Antrim , UK.

出版信息

Hum Vaccin Immunother. 2017 Jan 2;13(1):34-45. doi: 10.1080/21645515.2016.1239668. Epub 2016 Dec 9.

DOI:10.1080/21645515.2016.1239668
PMID:27936348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5287317/
Abstract

Nasal delivery offers many benefits over traditional approaches to vaccine administration. These include ease of administration without needles that reduces issues associated with needlestick injuries and disposal. Additionally, this route offers easy access to a key part of the immune system that can stimulate other mucosal sites throughout the body. Increased acceptance of nasal vaccine products in both adults and children has led to a burgeoning pipeline of nasal delivery technology. Key challenges and opportunities for the future will include translating in vivo data to clinical outcomes. Particular focus should be brought to designing delivery strategies that take into account the broad range of diseases, populations and healthcare delivery settings that stand to benefit from this unique mucosal route.

摘要

与传统的疫苗接种方法相比,鼻腔给药具有许多优势。这些优势包括无需打针即可轻松给药,减少了与针刺伤和处置相关的问题。此外,这种给药途径可轻松接触免疫系统的关键部分,从而刺激全身其他黏膜部位。成人和儿童对鼻腔疫苗产品的接受度不断提高,推动了鼻腔给药技术的蓬勃发展。未来的主要挑战和机遇将包括将体内数据转化为临床结果。应特别关注设计给药策略,要考虑到受益于这种独特黏膜给药途径的广泛疾病、人群和医疗保健环境。